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Abstract
This Editorial is to announce Particle and Fibre Toxicology, a new Open Access, peer-reviewed, online
journal published by BioMed Central. The field of particle and fibre toxicology has a long and
famous history stretching from Agricola and Paracelsus in the 15th and 16th century to the
challenges of the 21st century-nanoparticles, nanotubes and particulate matter (PM10) to name just
three. Throughout this time there has been no single journal dedicated to the toxicology of
particles and fibres and this is finally corrected by the launch of Particle and Fibre Toxicology. The
rationale for Particle and Fibre Toxicology rests on this need for a single multi-disciplinary journal that
can cover all research relevant to particle and fibre toxicology, from Hygiene studies, through
particle generation and characterisation, to animal, cell and human toxicology studies, dosimetry
and modelling. The editorial also deals with the philosophy and practicalities of Open Access
publishing, the journal's peer-review policy and conflict-of-interest. Particle and Fibre Toxicology is
aimed at bringing together multi-disciplinary research findings towards a better understanding of
how particles and fibres adversely affect the lungs and the body generally. We hope that the launch
of the new journal will aid in the advance of this important discipline to the greater benefit of
occupational and public health and invite scientists working in this key discipline to submit their
research.
Editorial
Particle and Fibre Toxicology is a new Open Access, peer-
reviewed, online journal published by BioMed Central,
which will publish articles pertaining to all aspects of the
toxicological effects of particles and fibres. Particles and
fibres are toxicologically important in many scenarios.
There is exposure, leading to adverse health effects, during
manufacture and use of industrial products, accidental
exposure during disturbance of the earth's crust in mining
and quarrying, accidental exposure from general anthro-
pogenic sources in the environment, and exposure to
organic particles containing biologically active com-
pounds such as endotoxins and glucans. Traditionally the
particles and fibres most intensively studied include,
PM10, PM2.5, asbestos, synthetic vitreous fibres, metals,
quartz (crystalline silica), and coalmine dust. There are,
however, numerous other particle types under study. The
diseases and conditions caused or affected by exposure to
particles include cancer, fibrosis, asthma, chronic obstruc-
tive pulmonary disease (COPD) and cardiovascular dis-
ease. Recently there has been increasing interest in the
extra-pulmonary effects of particles, such as transport of
particles to the blood and brain and the consequences of
such transport on neurological function, blood coagula-
tion and cardiovascular health.
Published: 03 December 2004
Particle and Fibre Toxicology 2004, 1:1 doi:10.1186/1743-8977-1-1
Received: 20 September 2004
Accepted: 03 December 2004
This article is available from: http://www.particleandfibretoxicology.com/content/1/1/1
© 2004 Donaldson and Borm; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Particle and Fibre Toxicology 2004, 1:1 http://www.particleandfibretoxicology.com/content/1/1/1
Page 2 of 3
(page number not for citation purposes)
Recently a whole new class of particles, those in the nan-
oparticle size range, have come under intense scrutiny.
Among those nanotubes and their toxicological effects are
also receiving increased attention. Nanoparticles are
increasingly used in 'Nanomedicine' for diagnostic, imag-
ing and therapeutic purposes and these require special
toxicological considerations [1].
Overview of journal scope
Particle and Fibre Toxicology welcomes manuscripts dealing
with the following toxicological aspects pertaining to par-
ticles and fibres: mechanistic studies, dosimetry, physico-
chemical factors in particle toxicity, animal studies, the
role of size in particle toxicity, the role of composition in
particle toxicity, cell studies, studies in acellular systems,
biopersistence and durability studies, studies aimed at
improving the dose metric, inhalation studies with real
and surrogate particles, mathematical modelling, deposi-
tion and clearance studies, anatomical and histological
studies, regulation and regulatory studies, pathology stud-
ies, risk assessment, translocation studies on the fate of
particles, and all toxicological studies that throw light on
how particles cause harmful effects in the lungs, liver,
blood and nervous system. Particle and Fibre Toxicology
especially welcomes manuscripts relating to the toxicolog-
ical hazards and risks of nanoparticles and nanotubes
especially when used for specific biomedical purposes.
The journal will consider the following types of article:
research, commentary, debate, hypothesis, methodology
articles, reviews and short reports.
Why is Particle and Fibre Toxicology needed?
The field of particle and fibre toxicology has a long and
famous history. During the 15th and 16th centuries Agri-
cola and Paracelsus were the first to document lung dis-
eases caused by inhalation of dust and by the time of the
Industrial Revolution in 18th and 19th century, the toll of
ill-health from dusty trades was enormous, with industrial
hygiene still in its infancy. By the 20th century the global
epidemic of lung disease caused by asbestos and crystal-
line silica demonstrated that the toxicology of dusts and
fibres was still 'a work in progress'. In the 21st century we
face the old challenges plus new ones, such as environ-
mental particulate air pollution, the new focus on the
extra-pulmonary effects of particles and potential risks
from nanoparticles arising from the nanotechnology
industry. A journal dedicated to the toxicology of particles
and fibres is a new and worthy addition to this long his-
tory.
Studies on topics related to particle and fibre toxicology
translate into thousands of scientific articles each year but
historically these have been scattered across numerous
journals. The target toxicology journal is usually chosen
on the basis of the endpoint under study, or if humans are
exposed, occupational and environmental journals may
be chosen. Those experienced in particle and fibre
research appreciate the special expertise required to carry
out and interpret toxicological studies because of poten-
tially confusing factors such as absorption, aggregation,
surface coating, dosimetry and overload. Such details are
not always appreciated by non-specialists. Particle and
Fibre Toxicology will provide a unique single outlet and
focus of expertise in this multi-disciplinary subject. Those
involved in research into particles and fibres include phys-
icists, chemists, materials scientists, environmental scien-
tists, hygienists, mechanistic toxicologists, inhalation
toxicologists, cell biologists, medical specialists, epidemi-
ologists and risk assessors. A single target journal special-
ising in particle and fibre toxicology will provide a focus
for the diverse community employed in this global
research enterprise. Focusing on the interface between
particles/fibres and humans, Particle and Fibre Toxicology
should aid in the advance of this important discipline to
the ultimate improvement of occupational and public
health.
Peer review policy
Publication of research articles in the broad area of parti-
cle toxicology is dependent on: relevance to the aims of
the journal; scientific validity and excellence; and coher-
ence with the research area as a whole, as judged by two
independent reviewers. An International Editorial Board
oversee the peer review of manuscripts submitted to Parti-
cle and Fibre Toxicology. Peer review is anonymous. A rec-
ommendation of acceptance or rejection is at the
discretion of the Editors based on the reviewers' recom-
mendations and will be agreed in consultation with the
reviewers. Articles will be published immediately upon
acceptance (after peer review) and soon after they will be
listed in PubMed and archived in PubMed Central.
Open Access
Particle and Fibre Toxicology's Open Access policy changes
the way in which articles are published. First, all articles
become freely and universally accessible online, and so an
author's work can be read by anyone at no cost. Second,
the authors hold copyright for their work and grant any-
one the right to reproduce and disseminate the article,
provided that it is correctly cited and no errors are intro-
duced [2]. Third, a copy of the full text of each Open
Access article is permanently archived in an online repos-
itory separate from the journal. Particle and Fibre Toxicol-
ogy's articles are archived in PubMed Central [3], the US
National Library of Medicine's full-text repository of life
science literature, and also in repositories at the University
of Potsdam [4] in Germany, at INIST [5] in France and in
e-Depot [6], the National Library of the Netherlands' dig-
ital archive of all electronic publications.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
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Open Access has four broad benefits for science and the
general public. First, authors are assured that their work is
disseminated to the widest possible audience, given that
there are no barriers to access their work. This is accentu-
ated by the authors being free to reproduce and distribute
their work, for example by placing it on their institution's
website. It has been suggested that free online articles are
more highly cited because of their easier availability [7].
Second, the information available to researchers will not
be limited by their library's budget, and the widespread
availability of articles will enhance literature searching
[8]. Third, the results of publicly funded research will be
accessible to all taxpayers and not just those with access to
a library with a subscription. As such, Open Access could
help to increase public interest in, and support of,
research. Note that this public accessibility may become a
legal requirement in the USA if the proposed Public
Access to Science Act is made law [9]. Fourth, a country's
economy will not influence its scientists' ability to access
articles because resource-poor countries (and institutions)
will be able to read the same material as wealthier ones
(although creating access to the internet is another matter
[10]).
Funding Open Access
6 months after the launch of Particle and Fibre Toxicology
all articles accepted by the journal will be subject to an
article processing charge of $525. The fee will be payable
by the authors unless their institution is a BioMed Central
member, but will be waived in cases of genuine hardship.
Conclusion
The information revolution is a double-edged sword felt
as keenly in science as anywhere else. We live in an age
where health science is a multimillion pound/euro/dollar
industry and its product, scientific articles, are produced
in vast numbers. Scientists and regulators struggle to find
this information and interpret it in ways that will benefit
human health. This is particularly relevant in toxicology
of particles and fibres because of its multidisciplinary
nature. Open access publishing clearly helps us make our
way through the forest of information by publishing rap-
idly and allowing easy access to research articles. Our new
journal Particle and Fibre Toxicology should also help by
acting as a focus for multidisciplinary research in this area.
We therefore look on Particle and Fibre Toxicology as a sig-
nificant opportunity to advance this important area of
public and occupational health and invite scientists in this
field to submit their work.
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